The best-selling drug Humira (adalimumab) now faces competition in the United States after a 20-year monopoly. The first adalimumab biosimilar, Amjevita, launched in the United States this past ...
Medicare Part D may cover Humira when a person can self-administer it at home. A person’s Part D costs for Humira will depend on the plan’s formulary and their specific plan. Similarly, Medicare ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Cigna Group-owned Evernorth Health Services said Thursday it would provide a Humira biosimilar with no out-of-pocket fees starting in June. The pharmacy and benefits provider said the biosimilar for ...
WASHINGTON (Reuters) - Abbott Laboratories Inc won a U.S. panel's support on Tuesday for wider use of its blockbuster rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel ...
Abbott Laboratories announced today that the U.S. Food and Drug Administration has granted expanded indication to the Company’s HUMIRA treatment to include inhibiting progression of structural joint ...
SAN FRANCISCO (MarketWatch) -- Abbott Laboratories said Monday that data from a Phase III extended study show that 74% of patients with moderate to severely active Crohn's disease who reached clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback